Vanda Pharmaceuticals (VNDA) Change in Acquisitions & Divestments (2010 - 2026)

Vanda Pharmaceuticals (VNDA) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $30.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 65.26% year-over-year to $30.5 million; the trailing twelve-month figure through Mar 2026 stood at $151.0 million (down 60.18% YoY), and the FY2025 full-year result was $208.2 million, down 40.85% from the prior year.
• Change in Acquisitions & Divestments fell to $30.5 million in Q1 2026, from $47.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $350.4 million in Q1 2023 to a low of $30.5 million in Q1 2026.
• A 5-year average of $93.7 million and a median of $82.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments soared 289.0% in 2023 and tumbled 82.73% in 2024, its largest moves.
• Tracing VNDA's Change in Acquisitions & Divestments over 5 years: stood at $80.0 million in 2022, then soared by 40.14% to $112.1 million in 2023, then fell by 13.83% to $96.6 million in 2024, then plunged by 51.35% to $47.0 million in 2025, then sank by 35.2% to $30.5 million in 2026.
• Business Quant data shows VNDA's Change in Acquisitions & Divestments at $30.5 million in Q1 2026, $47.0 million in Q4 2025, and $35.6 million in Q3 2025.